ARCHIVES

Study: End-of-Life Chemotherapy Leads to More Deaths in Hospital

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.

September 29, 2000

FDA Approves Rituxan For NHL With CHOP Therapy

February 24, 2006

Clinical Oncology Study Section In Draft; ET2 May Be Eliminated, NIH Official Says

February 13, 1998

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

November 2, 2007

Bennett, Federal Prosecutors Reach $475,000 Settlement

October 31, 2014

Bill to Rebalance Chemotherapy Drug Payments, Physician Services, Introduced in House

April 11, 2003